BAM
IDXX icon

Byrne Asset Management’s Idexx Laboratories IDXX Stock Holding History

Byrne Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.07K Hold
4
– – ﹤0.01% 577
2026
Q2 		$2.11K Hold
4
– – ﹤0.01% 549
2026
Q1 		$2.25K Hold
4
– – ﹤0.01% 520
2025
Q4 		$2.71K Buy
+4
New +$2.72K ﹤0.01% 508
2022
Q2 		– Sell
-142
Closed -$78K – 534
2022
Q1 		$78K Sell
142
-60
-30% -$31.6K 0.05% 183
2021
Q4 		$133K Buy
+202
New +$127K 0.09% 141

Other funds holding IDXX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BST
Bath Savings Trust Bath, Maine $966M AUM 9.35% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BAM
Bell Asset Management Melbourne, Australia $277M AUM 2.32% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
RSC
Red Spruce Capital Berwyn, Pennsylvania $283M AUM 29.49% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.31B AUM 12.25% 1-Year Est. Return

Byrne Asset Management's IDXX Position: Q3 2026 in Review

Byrne Asset Management held its Idexx Laboratories (IDXX) position steady in Q3 2026 at 4 shares worth $2.07K. The position accounts for ﹤0.01% of the portfolio, ranked #577.

Byrne Asset Management first reported a position in IDXX in Q4 2021 and has held it in 6 quarters since. The position peaked at $133K in Q4 2021. 33 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Byrne Asset Management held 4 shares of Idexx Laboratories worth $2.07K as of Q3 2026.
  • Byrne Asset Management left its Idexx Laboratories share count unchanged in Q3 2026.
  • Idexx Laboratories made up ﹤0.01% of Byrne Asset Management's portfolio in Q3 2026, its #577 holding.
  • Byrne Asset Management first reported a position in Idexx Laboratories in Q4 2021 and has held it in 6 quarters since.
  • Byrne Asset Management's Idexx Laboratories position peaked at $133K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Byrne Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.